Saturday, April 20, 2024
4/20/2024
Medicated Assisted Treatment-Prescription Drug and Opioid Addiction (MAT-PDOA) is an intermediate phase of intensive outpatient MAT that fills a service gap in Portland Community Health Center's existing MAT program. Portland CHC proposes adding two intermediate levels to serve as the bridge between our most intensive Phase-1 of MAT and the more traditional office-based Phases 4 and 5 of our Greater Pathways program. MAT-PDOA will provide targeted pharmacotherapy with psychosocial supports and community-based recovery resources to decrease diversion from treatment plans and misuse of medication. The patients with the strongest need for these services are residents of the greater Portland, Maine area, specifically those who live in resource-limited neighborhoods where opioid use disorder (OUD) is most prevalent. The MAT-PDOA program bridges a service gap in our current MAT programming to serve patients who fall between our most intensive daily supervised dosing program or more traditional office-based MAT programs. Strategies and interventions of the program include a flexible range of service times, access to specialized medical and behavioral health providers, individual counseling, outreach and peer support, case management, and linkages to a robust suite of community recovery and support resources. Goals of the project include: (1) Expanding and enhancing Portland CHC’s suite of treatment and recovery support services to more effectively identify, engage, and retain individuals in OUD treatment and facilitate long-term recovery; (2) Expanding regional access to MAT for OUDs to increase the number of individuals with OUD receiving MAT; and (3) Increasing the number of patients successfully engaging in MAT and long-term maintenance to decrease illicit opioid and prescription opioid misuse and facilitate long-term recovery. Objectives include: (1) Implementing referral and service delivery models specifically surrounding the MAT-PDOA program via outreach to Greater Portland Addiction Collaborative Partners; (2) Establishing funding mechanisms and service delivery models for the MAT-PDOA program with Preble Street Resource Center and University of Southern Maine; (3) Hiring all vacant key personnel and implement formalized policies for intake and treatment within the first year of funding; (4) Delivering services for up to 25 unique patients within the first year of funding; (5) Increasing the number of unique patients with OUD that Portland CHC’s waivered providers deliver MAT services to by 25 within the second year of funding; (6) Providing Sublocade pharmacotherapy and urine screening for up to three uninsured program participants within the first year; (7) Demonstrating a decrease in illicit drug and prescription opioid misuse in 50% of participants at 6-month follow-ups; (8) Maintaining an average of 25 unique MAT patients at any given time during the 5-year grant cycle (125 total).
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
